D Chao, M Su, M Sho, D Choi, S Tanlimco, H Kim, Y Zhang, J Yin, E D. Hsi, P Lambert, L Durkin, G Starling, D E.H Afar, P A. Culp. Correlation of TweakR Expression with Her2+ Ductal Breast Cancer and the Preclinical Therapeutic Effect of PDL192, a Humanized anti-TweakR antibody. EORTC 2009, poster presentation.

D Choi, J Yin, S Sze Tan, Y Zhang, D Chao, M Su, M Sho, P Seto, R Steinle, E Hsi,
V Ramakrishnan, PA Culp. PDL192, a Novel, Humanized Antibody to TWEAK Receptor, Shows Potent Anti-Tumor Activity in Preclinical Models. EORTC 2008, poster presentation.
PDL 241

Anti-TweakR Antibodies Inhibit Tumor Growth In Vivo Through Dual Mechanisms. AACR 2008 poster.